Conference Reports for NATAP

13th IAS Conference on HIV Science IAS 2026 July 26-31 Rio, Brazil Back

Metabolic Changes at 48 Weeks in People With HIV and Virologic Suppression Switching to Single-Tablet Bictegravir/Lenacapavir From Complex Antiretroviral Regimens: Results From the Phase 3 ARTISTRY-1 Trial       IAS 2026 Rio, Brazil